1990
DOI: 10.1016/0304-3959(90)91153-a
|View full text |Cite
|
Sign up to set email alerts
|

Does capsaicin relieve the pain of diabetic neuropathy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0
2

Year Published

1991
1991
2012
2012

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 78 publications
(28 citation statements)
references
References 7 publications
0
26
0
2
Order By: Relevance
“…Four studies identified (Basha 1991;Donofrio 1991;Scheffler 1991;Tandan 1992) were reports of parts of a multicentre study (CSG 1992), only one of which (Tandan 1992, 22 participants) provided any additional data. Eleven other studies were excluded after reading the full report (Chad 1990;Fusco 1992;McCarty 1994;McCleane 2000;Paice 2000;Peikert 1991;Pfeifer 1993;Robbins 1998;Vickers 1998;Watson 1988;Watson 1989). Reasons for exclusion are in the 'Characteristics of excluded studies' table.…”
Section: Description Of Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Four studies identified (Basha 1991;Donofrio 1991;Scheffler 1991;Tandan 1992) were reports of parts of a multicentre study (CSG 1992), only one of which (Tandan 1992, 22 participants) provided any additional data. Eleven other studies were excluded after reading the full report (Chad 1990;Fusco 1992;McCarty 1994;McCleane 2000;Paice 2000;Peikert 1991;Pfeifer 1993;Robbins 1998;Vickers 1998;Watson 1988;Watson 1989). Reasons for exclusion are in the 'Characteristics of excluded studies' table.…”
Section: Description Of Studiesmentioning
confidence: 99%
“…Similarly, investigator or physician reported outcomes do not reliably correspond to patient outcomes. In particular, four studies of 4 weeks' duration were excluded (Chad 1990;McCarty 1994;McCleane 2000;Paice 2000). These studies enrolled 329 participants, 90 of whom were treated with 0.075% capsaicin, and 21 with 0.025% capsaicin.…”
Section: Overall Completeness and Applicability Of Evidencementioning
confidence: 99%
“…32,36 -38 Two reported significant improvements in all three outcome measures at 8 weeks, 32,37 whereas two reported significant improvements in only one outcome measure at 4 to 8 weeks. 36,38 In most trials, patients were more likely to experience burning after application with capsaicin (60% to 63%) compared with placebo (17% to 20%), which could have affected blinding. The largest trial also had a significantly higher dropout Diabetic Peripheral Neuropathy 53 on 28 April 2019 by guest.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…Capsaicin has been investigated as a topical application for diabetic [325][326][327][328][329] and HIV peripheral neuropathy [330][331][332]. The majority of studies have been conducted on diabetes PN with most resulting in statistical significance [325][326][327][328][329].…”
Section: -114mentioning
confidence: 99%
“…The majority of studies have been conducted on diabetes PN with most resulting in statistical significance [325][326][327][328][329]. The results indicate that capsaicin cream may provide relief for chronic, intractable pain and reduce dependence on opioids however the main side effect of burning at the site of application may be of concern [329].…”
Section: -114mentioning
confidence: 99%